Four-year Result of Diffusion-Weighted, MRI-guided, Dose-Painting Radiotherapy Following Induction Chemotherapy in Patients with Locally Advanced Recurrent Nasopharyngeal Carcinoma: A Randomized Controlled Trial.
Feng Liu,Cuihong Jiang,Xiangwei Wu,Wen Liu,Changgen Fan,Lili He,Shuai Xiao,Yanxian Li,Xu Ye,Wenqiong Wu,Qi Zhao,Hui Wang
DOI: https://doi.org/10.1200/jco.2022.40.16_suppl.6033
IF: 45.3
2022-01-01
Journal of Clinical Oncology
Abstract:6033 Background: We hypothesized that diffusion-weighted MR imaging (DWI) guided dose-painting radiotherapy (DP-RT) following induction chemotherapy (IC)was associated with improved local tumor control and progression-free survival compared with conventional MRI-based radiotherapy (RT) in locally advanced recurrentnasopharyngeal carcinoma (rNPC). The purpose of this randomized phase II trial was to compare the efficacy and toxicity of DWI guided DP-RT following IC versus standard conventional MRI-based radiotherapy following IC in locally advanced rNPC. Methods: Tow hundred and four patients with locally recurrent T3 to T4 NPC were randomly assigned to receive DWI-guided dose-painting radiotherapy (DP-RT) or conventional MRI-based radiotherapy. Patients in both groups received reirradiation using intensity modulated radiation therapy (IMRT) following cisplatin-based induction chemotherapy. In DP-RT group (group A, n = 102), subvolume GTVnx-DWI (gross tumor volume of nasopharynx in DWI) was defined as the areas within the GTVnx (gross tumor volume of nasopharynx) with an apparent diffusion coefficient (ADC) below the mean ADC (ADC < mean). The dose to GTVnx-DWI was escalated to DT 65.4 Gy/30 Fx in 2.18 Gy per fraction. In conventional MRI-based RT group (group B), PGTVnx was irradiated at DT 60.0 Gy/30 Fx in 2.0 Gy per fraction. This trial is registered with chictr.org.cn, number ChiCTR2100052340. Results: Compared with conventional MRI-based radiotherapy, DWI-guided DP-RT significantly improved 4-year progression-free survival (PFS, 48.0% vs. 33.3%; P = 0.033), local control rate (LC, 85.3% vs. 69.6%; P = 0.007), and overall survival (OS, 52.0% vs. 37.3%; P = 0.035). No statistically significant differences in acute and late toxic effects (mucosal necrosis, trismus, temporal lobe necrosis, and cranial nerve palsy) were observed between the two groups. Dose painting (DWI-guided DP-RT vs conventional MRI-based RT) was a significant independent prognostic factor for PFS and LC (P = 0.035 and P = 0.020, respectively). Conclusions: Diffusion-weighted MRI guided dose-painting radiotherapy following induction chemotherapy is associated with a considerable progression-free survival and local control benefit, without increasing toxicity, as compared with standard conventional MRI-based RT following IC, among patients with locally recurrent T3 to T4 nasopharyngeal carcinoma. Clinical trial information: ChiCTR2100052340.